is retatrutide available in the us Retatrutide, an experimental weight-loss drug, has not been approved by FDA. But, doctors and nurse practitioners clinics across the country are prescribing it anyway, a CBS News investigation found. @adamyamaguchi GLP-3 RT – True Lab

P., and Checler F

Some patients use a maintenance plan for a few months, while others may need longer support depending on their goals, response to medication, and overall health

Retatrutide has shown strong weight-loss signals in clinical trials, but it is still being studied

Given the rapid evolution of this field, future breakthroughs, including new drug approvals and expanded indications, necessitate systematic updates of the literature

However, given that GLP-1 drugs are currently not covered by Medicare or Medicaidor most private insurancethe announcement from Trump represents a big change in how the federal government sees these obesity treatments